Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Outcome after endovascular therapy of ruptured intracranial aneurysms: morbidity and impact of rebleeding

Kremer, Christine LU ; Groden, C ; Lammers, G ; Weineck, G ; Zeumer, H and Hansen, H C (2002) In Neuroradiology 44(11). p.942-945
Abstract
We evaluated midterm functional outcome after endovascular occlusion of aneurysms in patients with subarachnoid haemorrhage (SAH) and determined the incidence of late rebleeding as an additional prognostic parameter. We treated 79 consecutive patients with SAH from an intracranial aneurysm admitted from a neurological intensive care unit by the endovascular route between 1993 and 1997 and 52 survivors were followed up in 1999-2000. The mean interval between SAH and follow-up was 41 months (range 13-74 months). Outcome was determined by the Glasgow outcome (GOS) and Rankin (RS) scales and by questions concerning neuropsychological disorders. The patients were analysed according to Hunt and Hess (H & H) grades I-III or IV-V on admission.... (More)
We evaluated midterm functional outcome after endovascular occlusion of aneurysms in patients with subarachnoid haemorrhage (SAH) and determined the incidence of late rebleeding as an additional prognostic parameter. We treated 79 consecutive patients with SAH from an intracranial aneurysm admitted from a neurological intensive care unit by the endovascular route between 1993 and 1997 and 52 survivors were followed up in 1999-2000. The mean interval between SAH and follow-up was 41 months (range 13-74 months). Outcome was determined by the Glasgow outcome (GOS) and Rankin (RS) scales and by questions concerning neuropsychological disorders. The patients were analysed according to Hunt and Hess (H & H) grades I-III or IV-V on admission. We observed two episodes of rebleeding (3%) with impact on outcome at 907 and 2010 days after SAH, respectively. A complete recovery (GOS 5) was achieved in 53% of H & H grade I-III and 17% of grade IV-V patients; with death rates 19% and 50%, and morbidity according to the RS (5-2) 18% and 29%, respectively. Midterm morbidity after endovascular therapy is thus low. Rebleeding with an impact on outcome can be observed up to 2010 days after SAH, suggesting that long-term angiographic follow-up is indispensable. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; and
publishing date
type
Contribution to journal
publication status
published
subject
in
Neuroradiology
volume
44
issue
11
pages
942 - 945
publisher
Springer
external identifiers
  • pmid:12428132
  • scopus:0036943039
ISSN
1432-1920
DOI
10.1007/s00234-002-0849-0
language
English
LU publication?
no
additional info
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Neurology, Malmö (013027010), External organization(s) (LUR000040)
id
b95c1477-c495-4e50-ac32-659e197f964f (old id 1125260)
date added to LUP
2016-04-01 12:08:03
date last changed
2022-02-26 02:19:08
@article{b95c1477-c495-4e50-ac32-659e197f964f,
  abstract     = {{We evaluated midterm functional outcome after endovascular occlusion of aneurysms in patients with subarachnoid haemorrhage (SAH) and determined the incidence of late rebleeding as an additional prognostic parameter. We treated 79 consecutive patients with SAH from an intracranial aneurysm admitted from a neurological intensive care unit by the endovascular route between 1993 and 1997 and 52 survivors were followed up in 1999-2000. The mean interval between SAH and follow-up was 41 months (range 13-74 months). Outcome was determined by the Glasgow outcome (GOS) and Rankin (RS) scales and by questions concerning neuropsychological disorders. The patients were analysed according to Hunt and Hess (H & H) grades I-III or IV-V on admission. We observed two episodes of rebleeding (3%) with impact on outcome at 907 and 2010 days after SAH, respectively. A complete recovery (GOS 5) was achieved in 53% of H & H grade I-III and 17% of grade IV-V patients; with death rates 19% and 50%, and morbidity according to the RS (5-2) 18% and 29%, respectively. Midterm morbidity after endovascular therapy is thus low. Rebleeding with an impact on outcome can be observed up to 2010 days after SAH, suggesting that long-term angiographic follow-up is indispensable.}},
  author       = {{Kremer, Christine and Groden, C and Lammers, G and Weineck, G and Zeumer, H and Hansen, H C}},
  issn         = {{1432-1920}},
  language     = {{eng}},
  number       = {{11}},
  pages        = {{942--945}},
  publisher    = {{Springer}},
  series       = {{Neuroradiology}},
  title        = {{Outcome after endovascular therapy of ruptured intracranial aneurysms: morbidity and impact of rebleeding}},
  url          = {{http://dx.doi.org/10.1007/s00234-002-0849-0}},
  doi          = {{10.1007/s00234-002-0849-0}},
  volume       = {{44}},
  year         = {{2002}},
}